NYSE:STVN - New York Stock Exchange, Inc. - IT0005452658 - Common Stock - Currency: USD
21.81
+0.2 (+0.93%)
The current stock price of STVN is 21.81 USD. In the past month the price increased by 3.32%. In the past year, price decreased by -20.81%.
Symbol | Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
TMO | THERMO FISHER SCIENTIFIC INC | 19.71 | 162.94B | ||
DHR | DANAHER CORP | 26.35 | 140.45B | ||
A | AGILENT TECHNOLOGIES INC | 19.77 | 29.94B | ||
IQV | IQVIA HOLDINGS INC | 13.2 | 25.93B | ||
MTD | METTLER-TOLEDO INTERNATIONAL | 25.42 | 21.80B | ||
WAT | WATERS CORP | 28.21 | 19.92B | ||
WST | WEST PHARMACEUTICAL SERVICES | 32.32 | 15.77B | ||
ILMN | ILLUMINA INC | 31.12 | 12.07B | ||
ICLR | ICON PLC | 10.22 | 11.82B | ||
RVTY | REVVITY INC | 19.12 | 11.26B | ||
AVTR | AVANTOR INC | 15.47 | 10.54B | ||
QGEN | QIAGEN N.V. | 19.15 | 9.15B |
Stevanato Group SpA engages in the provision of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries. The company is headquartered in Piombino Dese, Padova and currently employs 5,521 full-time employees. The company went IPO on 2021-07-16. The firm delivers products, processes, and services across all stages of drug developments, including pre-clinical, clinical, and commercialization. Its Engineering segment includes the equipment and technologies developed and provided to support the end-to-end pharmaceutical, biotechnology, and diagnostic manufacturing processes. The firm operates locally, in Europe, and globally, including Brazil, China, Mexico, and the United States.
STEVANATO GROUP SPA
Piombino Dese (Pd) Via Molinella, 17
Piombino Dese PADOVA IT
CEO: Franco Moro
Employees: 5635
Company Website: https://www.stevanatogroup.com/
Investor Relations: https://ir.stevanatogroup.com/
Phone: 390499318173
The current stock price of STVN is 21.81 USD. The price increased by 0.93% in the last trading session.
The exchange symbol of STEVANATO GROUP SPA is STVN and it is listed on the New York Stock Exchange, Inc. exchange.
STVN stock is listed on the New York Stock Exchange, Inc. exchange.
16 analysts have analysed STVN and the average price target is 27.47 USD. This implies a price increase of 25.95% is expected in the next year compared to the current price of 21.81. Check the STEVANATO GROUP SPA stock analysts ratings, price target forecast and up-and down grades for more detailed information.
STEVANATO GROUP SPA (STVN) has a market capitalization of 5.95B USD. This makes STVN a Mid Cap stock.
STEVANATO GROUP SPA (STVN) currently has 5635 employees.
STEVANATO GROUP SPA (STVN) has a support level at 21.72 and a resistance level at 22.53. Check the full technical report for a detailed analysis of STVN support and resistance levels.
The Revenue of STEVANATO GROUP SPA (STVN) is expected to grow by 7.25% in the next year. Check the estimates tab for more information on the STVN EPS, Sales, EBIT and EBITDA future analyst estimates.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
STEVANATO GROUP SPA (STVN) has a dividend yield of 0.26%. The yearly dividend amount is currently 0.06. Check the full fundamental report for a detailed analysis of STVN dividend history, reliability and sustainability.
STEVANATO GROUP SPA (STVN) will report earnings on 2025-05-07, after the market close.
The PE ratio for STEVANATO GROUP SPA (STVN) is 39.65. This is based on the reported non-GAAP earnings per share of 0.55 and the current share price of 21.81 USD. Check the full fundamental report for a full analysis of the valuation metrics for STVN.
The outstanding short interest for STEVANATO GROUP SPA (STVN) is 7.27% of its float. Check the ownership tab for more information on the STVN short interest.
ChartMill assigns a technical rating of 6 / 10 to STVN. When comparing the yearly performance of all stocks, STVN is a bad performer in the overall market: 63.97% of all stocks are doing better.
ChartMill assigns a fundamental rating of 5 / 10 to STVN. While STVN has a great profitability rating, there are some minor concerns on its financial health.
Over the last trailing twelve months STVN reported a non-GAAP Earnings per Share(EPS) of 0.55. The EPS decreased by -17.24% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | 10.67% | ||
ROA | 5.06% | ||
ROE | 8.39% | ||
Debt/Equity | 0.26 |
ChartMill assigns a Buy % Consensus number of 83% to STVN. The Buy consensus is the average rating of analysts ratings from 16 analysts.
For the next year, analysts expect an EPS growth of 12.62% and a revenue growth 7.25% for STVN